Sing Tao <<星島日報>> newspaper reported the birth of Olivia, the first child in Canada to be conceived with the help of the Early Embryo Viability Assesment (Eeva) Test. Olivia’s mother, 40 year-old Darla Macey-Nicholson, is ecstatic about the latest addition to her family.
To view Sing Tao’s coverage of the exciting announcement, please click here or the image below.
Darla Macey-Nicholson, mother of Olivia – the first child conceived with the help of the Early Embryo Viability Assessment (Eeva) Test, had a chance to sit down with 24 Hours’ Jane Deacon and to explain why the groundbreaking reproductive technology is so important to her.
CTV Vancouver’s Maria Weisgarber had a chance to visit our clinic yesterday when Darla Macey-Nicholson and her lovely almost-five-week-old baby, Olivia, dropped by. Olivia is the first baby in Canada conceived with the assistance of the Early Embryo Viability Assessment (Eeva) Test.
Maria sat down with our medical director, Dr. Sonya Kashyap, to talk about the Eeva Test and whether taxpayers should help fund fertility treatments. Dr. Kashyap touched upon this subject earlier in the year when the National Post published an opinion piece titled “Pregnancy is a want, not a need.”
Click here or the image below to see what Dr. Kashyap and Darla had to say:
Vancouver, B.C. – September 24, 2014 – The first baby in Canada conceived with the assistance of the Early Embryo Viability Assessment (Eeva®) Test at Vancouver’s Genesis Fertility Centre was born this past August. Olivia, born to Darla Macey-Nicholson and Craig Nicholson, was conceived through in vitro fertilization (IVF) with the help of novel embryo development information provided by the Eeva®Test.
The Eeva® Test, which is exclusively distributed in Canada by EMD Serono, a division of EMD Inc., Canada, is a significant innovation for reproductive technology. The test is a tool which helps embryologists in assessing the embryo most likely to develop for implantation, ultimately aiding fertility experts achieve better outcomes for their patients. Developed by Auxogyn Inc., a company dedicated to advancing women’s reproductive health, the Eeva® Test is based on patented technology developed by StanfordUniversity researchers. This team of university researchers is world-renowned for pioneering techniques in time-lapse imaging of stem cells.
“We are honoured to have helped conceive the first Eeva® baby in Canada,” says Dr. Sonya Kashyap MD, medical director of Genesis Fertility Centre. “It demonstrates that Eeva can act as a tool to improve success rates of IVF in addition to increasing patients’ overall experience to achieve pregnancy. These are our two most important goals.”
We’ve been featured in “Canada’s Premiere South Asian Lifestyle Magazine”! Drishti Magazine had a chance to interview our medical director, Dr. Sonya Kashyap, about the use of Early Embryo Viability Assessment (Eeva), the first use of the assisted reproductive technology in Canada.
To view the article, please click here or the image below!